World journal of urology

publication venue for

Correction to: Unintended consequences of decreased PSA-based prostate cancer screening. 2020
Diagnosis and management of incidental ureterocele during the treatment of clinically localized prostate cancer. 2000
Recurrent UTI quality of life questionnaire: pilot study evaluating the impact of recurrent urinary tract infection on quality of life in postmenopausal women.. 44. 2026
Who still needs multiple access sites in the era of ECIRS and US-guided supine PCNL?. 44. 2026
World-wide variation in percutaneous nephrolithotomy practices: evaluation based on training, experience, and region.. 43. 2025
Evaluation of a fluoroscopy-free, ureteral access sheath-free, and stent-free approach to retrograde intrarenal surgery.. 43. 2025
Does having an asymptomatic renal stone increase morbidity after radical cystectomy?. 43. 2025
Knowledge and self-confidence of healthcare workers to perform transurethral catheterization: a matter deserving attention!. 43. 2025
Factors affecting the non-publication of clinical trials of prevalent urological cancer.. 42. 2024
Gender inequality in genitourinary malignancies clinical trials leadership.. 42. 2024
Comparison of metabolic parameters between pure-uric acid and mixed-uric acid kidney stone formers.. 42. 2024
Empiric versus culture-based antibiotic therapy for UTIs in menopausal women.. 41. 2023
Racial and socioeconomic disparities in cost and postoperative complications following sacrocolpopexy in a US National Inpatient Database.. 41. 2022
Prostatic artery embolization compared to transurethral resection of the prostate and prostatic urethral lift: a real-world population-based study.. 41. 2022
Development of a North American coordinated registry network for surgical treatment of benign prostatic hyperplasia. 2022
Evaluating the association between food insecurity and risk of nephrolithiasis: an analysis of the National Health and Nutrition Examination Survey.. 40. 2022
Incidence of venous thromboembolism in benign urologic reconstructive cases.. 40. 2022
Natural history of lower urinary tract symptoms among men undergoing stereotactic body radiation therapy for prostate cancer with and without a Rectal Hydrogel Spacer.. 40. 2022
Real-world data comparing minimally invasive surgeries for benign prostatic hyperplasia.. 40. 2022
Association of age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer.. 39. 2021
Safety and efficacy of TURP vs. laser prostatectomy for the treatment of benign prostatic hyperplasia in multi-morbid and elderly individuals aged ≥ 75.. 39. 2021
Frailty as predictor of complications in patients undergoing percutaneous nephrolithotomy (PCNL).. 39. 2021
Real-world comparative effectiveness of shockwave lithotripsy versus ureterorenoscopy for the treatment of urinary stones.. 39. 2020
The association between plant-based content in diet and testosterone levels in US adults.. 39. 2020
Dependence of laser-induced tissue ablation on optical fiber movements for laser prostatectomy.. 38. 2019
Comparison of clinical outcomes and automated performance metrics in robot-assisted radical prostatectomy with and without trainee involvement.. 38. 2019
Complication rate after cystectomy following pelvic radiotherapy: an international, multicenter, retrospective series of 682 cases.. 38. 2019
Propensity-matched analysis of patient-reported outcomes for neoadjuvant chemotherapy prior to radical cystectomy.. 37. 2019
Impact of intravesical therapy for non-muscle invasive bladder cancer on the accuracy of urine cytology.. 37. 2019
Focal laser ablation as clinical treatment of prostate cancer: report from a Delphi consensus project.. 37. 2019
Development and external validation of a pathological nodal staging score for patients with clear cell renal cell carcinoma.. 37. 2018
The effect of androgen deprivation treatment on subsequent risk of bladder cancer diagnosis in male patients treated for prostate cancer.. 37. 2018
Predictors of oncological outcomes in T1G3 patients treated with BCG who undergo radical cystectomy.. 36. 2018
Unintended consequences of decreased PSA-based prostate cancer screening.. 37. 2018
Salvage topical therapy for upper tract urothelial carcinoma.. 36. 2018
Recurrence, progression and cancer-specific mortality according to stage at re-TUR in T1G3 bladder cancer patients treated with BCG: not as bad as previously thought.. 36. 2018
A contemporary lower pole approach for complete staghorn calculi: outcomes and efficacy.. 36. 2018
Accuracy and prognostic value of variant histology and lymphovascular invasion at transurethral resection of bladder.. 36. 2017
Minimally invasive vs open nephrectomy in the modern era: does approach matter?. 35. 2017
Trends of lymphadenectomy in upper tract urothelial carcinoma (UTUC) patients treated with radical nephroureterectomy.. 35. 2017
The impact of socioeconomic status on perioperative complications and oncologic outcomes in patients undergoing radical cystectomy.. 35. 2016
Prognostic role of expression of N-cadherin in patients with upper tract urothelial carcinoma: a multi-institutional study.. 35. 2016
Contemporary treatment patterns and outcomes of sarcomatoid bladder cancer.. 35. 2016
Androgen receptor expression is associated with adverse pathological features in ureteral but not in pelvicalyceal urothelial carcinomas of the upper urinary tract.. 35. 2016
Impact of tumor histology and grade on treatment success of percutaneous renal cryoablation.. 35. 2016
Prognostic role of decreased E-cadherin expression in patients with upper tract urothelial carcinoma: a multi-institutional study.. 35. 2016
Obstructive sleep apnea and Fuhrman grade in patients with clear cell renal cell carcinoma treated surgically.. 35. 2016
Second primary malignancies in renal cortical neoplasms: an updated evaluation from a single institution.. 34. 2016
Prognostic role of ERCC1 protein expression in upper tract urothelial carcinoma following radical nephroureterectomy with curative intent.. 34. 2015
Low yield of surveillance imaging after surgery for T1 kidney cancer.. 34. 2015
Histologic subtype impacts cancer-specific survival in patients with sarcomatoid-variant renal cell carcinoma treated surgically.. 34. 2015
Partial nephrectomy for renal tumors in solitary kidneys: postoperative renal function dynamics.. 33. 2015
Multicenter evaluation of the role of UroVysion FISH assay in surveillance of patients with bladder cancer: does FISH positivity anticipate recurrence?. 33. 2014
Postoperative complications and short-term oncological outcomes of patients aged ≥80 years undergoing robot-assisted radical cystectomy.. 33. 2014
Multi-institutional validation of the prognostic value of Ki-67 labeling index in patients treated with radical prostatectomy.. 33. 2014
Insignificant disease among men with intermediate-risk prostate cancer.. 32. 2014
Interobserver variability of R.E.N.A.L., PADUA, and centrality index nephrometry score systems.. 33. 2014
Impact of warm versus cold ischemia on renal function following partial nephrectomy.. 33. 2014
Analysis of lymph node dissection in patients with ≥7-cm renal tumors.. 32. 2014
Non-squamous cell carcinoma of the penis: single-center, 15-year experience.. 32. 2013
Lower urinary tract symptoms improve with testosterone replacement therapy in men with late-onset hypogonadism: 5-year prospective, observational and longitudinal registry study.. 32. 2013
Association of diabetes mellitus and metformin use with biochemical recurrence in patients treated with radical prostatectomy for prostate cancer.. 32. 2013
The hypothalamic-pituitary-gonadal axis and prostate cancer: implications for androgen deprivation therapy.. 32. 2013
Urodynamic characterization of lower urinary tract symptoms in men less than 40 years of age.. 32. 2013
The impact of smoking on pathologic response to neoadjuvant cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer.. 32. 2013
Use of the Bulbocavernosus Reflex System in assessing voiding dysfunction.. 31. 2013
Functional outcomes following robotic prostatectomy using athermal, traction free risk-stratified grades of nerve sparing.. 31. 2013
Female gender is associated with higher risk of disease recurrence in patients with primary T1 high-grade urothelial carcinoma of the bladder.. 31. 2012
Effect of minimizing tension during robotic-assisted laparoscopic radical prostatectomy on urinary function recovery.. 31. 2012
Accurate risk assessment of patients with asymptomatic hematuria for the presence of bladder cancer.. 30. 2012
Disease-free survival as a surrogate for overall survival in upper tract urothelial carcinoma.. 31. 2012
Does increasing the nodal yield improve outcomes in patients without nodal metastasis at radical cystectomy?. 30. 2012
Evaluating the Prostate Cancer Prevention Trial High Grade Prostate Cancer Risk Calculator in 10 international biopsy cohorts: results from the Prostate Biopsy Collaborative Group.. 32. 2012
Evaluating the PCPT risk calculator in ten international biopsy cohorts: results from the Prostate Biopsy Collaborative Group.. 30. 2011
Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the prostate biopsy collaborative group.. 30. 2011
Predicting prostate cancer many years before diagnosis: how and why?. 30. 2011
Multicenter validation of the prognostic value of patient age in patients treated with radical cystectomy.. 30. 2011
Preoperative radiographic parameters predict long-term renal impairment following partial nephrectomy.. 31. 2011
Chronological age is not an independent predictor of clinical outcomes after radical nephroureterectomy.. 29. 2011
Nerve-sparing technique and urinary control after robot-assisted laparoscopic prostatectomy.. 29. 2010
Gender differences in radical nephroureterectomy for upper tract urothelial carcinoma.. 29. 2010
Application of new technology in bladder cancer diagnosis and treatment.. 27. 2009
From proficiency to expert, when does the learning curve for robotic-assisted prostatectomies plateau? The Columbia University experience.. 25. 2007
Female sexual dysfunction, voiding symptoms and depression: common findings in partners of men with erectile dysfunction.. 24. 2006
Gleason score and pretreatment prostate-specific antigen in survival among patients with stage D2 prostate cancer.. 22. 2004
Transforming growth factor-beta localization during mouse prostate morphogenesis and in prostatic growth abnormalities.. 13. 1995
Challenges in testicular cancer management.. 27. 2009
Diagnostic efficacy of serum microRNAs in predicting pathology of retroperitoneal lymph node dissection in patients with testicular germ cell tumors: a systematic review and meta-analysis. 2025
Female sexual function evaluation and intraoperative vaginal reconstruction in bladder cancer. 2023
Management of large kidney stones in the geriatric population. 2023
Incidence and risk factors for postoperative urinary incontinence after various prostate enucleation procedures: systemic review and meta-analysis of PubMed literature from 2000 to 2021. 2022
Posterior urethral stenosis: a comparative review of the guidelines. 2022
Comparative review of the guidelines for anterior urethral stricture. 2022
The evolution and resurgence of perineal prostatectomy in the robotic surgical era. 2019
Prognostic value of T1 substaging on oncological outcomes in patients with non-muscle-invasive bladder urothelial carcinoma: a systematic literature review and meta-analysis. 2019
The molecular limitations of biomarker research in bladder cancer. 2018
Upper tract urothelial carcinoma topical issue 2016: treatment of metastatic cancer. 2016
Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of localized high-risk disease. 2016
Current controversies and challenges in robotic-assisted, laparoscopic, and open partial nephrectomies. 2014
Predictive factors of recurrence and survival of upper tract urothelial carcinomas. 2011
Outcomes assessment in men undergoing open retropubic radical prostatectomy, laparoscopic radical prostatectomy, and robotic-assisted radical prostatectomy. 2011
Health services research in urology. 2011
Salvage robotic assisted laparoscopic radical prostatectomy: indications and outcomes. 2010
Good-risk-advanced germ cell tumors: historical perspective and current standards of care. 2009
Radical prostatectomy for high-risk prostate cancer. 2008
Understanding the needs and objectives of erectile dysfunction patients. 2006
Staged based directed surveillance of invasive bladder cancer following radical cystectomy: valuable and effective? 2006
State-of-the-art management of metastatic disease at initial presentation or recurrence. 2006
New drugs and new approaches for the treatment of metastatic urothelial cancer. 2002
Neo-adjuvant chemotherapy in invasive bladder cancer. 2001
Adrenocortical carcinoma. 1999
Natural history of superficial bladder tumors: 10- to 20-year follow-up of treated patients. 1997
Adjuvant chemotherapy following radical cystectomy. 1993
SIU-ICUD recommendations on bladder cancer: systemic therapy for metastatic bladder cancer. 2018

VIVO Weill Cornell Medical College

World journal of urology Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)